Ivan Gergel

Ivan Gergel serves as the Chairman of the Board of Directors at Corsair Pharma and holds directorial roles at Theranica Bio-Electronics Ltd., Butterfly Medical, and Neuraptive Therapeutics. As a Managing Partner and Chief Medical Officer at New Rhein Healthcare Investors, significant leadership is demonstrated across various healthcare organizations. Previous directorships include positions at Travecta Therapeutics, Neurotrope Inc., Realm Therapeutics, and Corium. Gergel has extensive experience in medical and business leadership, bolstered by a Doctor of Medicine degree from the University of London, MRCPsych from the Royal College of Psychiatrists, and an MBA from The Wharton School.